Hologic Valuation
| HOLX Stock | USD 79.39 0.63 0.80% |
At this time, the firm appears to be undervalued. Hologic retains a regular Real Value of $83.47 per share. The prevalent price of the firm is $79.39. Our model calculates the value of Hologic from evaluating the firm fundamentals such as Return On Equity of 0.14, current valuation of 18.49 B, and Return On Asset of 0.0645 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Hologic's valuation include:
Price Book 3.566 | Enterprise Value 18.5 B | Enterprise Value Ebitda 14.2684 | Price Sales 4.6244 | Forward PE 18.4843 |
Undervalued
Today
Please note that Hologic's price fluctuation is very steady at this time. Calculation of the real value of Hologic is based on 3 months time horizon. Increasing Hologic's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Hologic is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Hologic Stock. However, Hologic's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 79.39 | Real 83.47 | Target 86.62 | Hype 79.4 | Naive 77.17 |
The intrinsic value of Hologic's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Hologic's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Hologic helps investors to forecast how Hologic stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Hologic more accurately as focusing exclusively on Hologic's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Hologic's intrinsic value based on its ongoing forecasts of Hologic's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Hologic's closest peers.
Hologic Cash |
|
Hologic Valuation Trend
Analysing the historical paterns of Hologic's enterprise value and its market capitalization is a good way to estimate and gauge the value of Hologic over time and is usually enough for investors to make rational market timing decisions.
Hologic Total Value Analysis
Hologic is currently expected to have valuation of 18.49 B with market capitalization of 18.44 B, debt of 2.53 B, and cash on hands of 2.39 B. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Hologic fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
18.49 B | 18.44 B | 2.53 B | 2.39 B |
Hologic Investor Information
About 99.0% of the company shares are owned by institutional investors. The book value of Hologic was currently reported as 21.34. The company has Price/Earnings To Growth (PEG) ratio of 1.27. Hologic had not issued any dividends in recent years. The entity had 2:1 split on the 3rd of April 2008. Based on the measurements of operating efficiency obtained from Hologic's historical financial statements, Hologic is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in December.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.23 | 0.219 |
|
|
Hologic Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Hologic has an asset utilization ratio of 44.02 percent. This suggests that the Company is making $0.44 for each dollar of assets. An increasing asset utilization means that Hologic is more efficient with each dollar of assets it utilizes for everyday operations.Hologic Ownership Allocation
The majority of Hologic outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Hologic to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Hologic. Please pay attention to any change in the institutional holdings of Hologic as this could imply that something significant has changed or is about to change at the company. On December 12, 2018, Senator John Reed of US Senate acquired under $15k worth of Hologic's common stock.Hologic Profitability Analysis
The company reported the previous year's revenue of 4.03 B. Net Income was 789.5 M with profit before overhead, payroll, taxes, and interest of 2.48 B.About Hologic Valuation
Our relative valuation model uses a comparative analysis of Hologic. We calculate exposure to Hologic's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Hologic's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.2 B | 2.3 B | |
| Pretax Profit Margin | 0.21 | 0.23 | |
| Operating Profit Margin | 0.22 | 0.23 | |
| Net Profit Margin | 0.20 | 0.21 | |
| Gross Profit Margin | 0.55 | 0.39 |
Hologic Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 237.6 M | |
| Quarterly Earnings Growth Y O Y | 1.116 | |
| Forward Price Earnings | 18.4843 |
Hologic Current Valuation Indicators
Valuation refers to the process of determining the present value of Hologic and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Hologic we look at many different elements of the entity such as Hologic's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Hologic, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Hologic's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Hologic's worth.Additional Tools for Hologic Stock Analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.